SAN DIEGO--June 4, 2006--Siemens Medical Solutions showcased the industry's most comprehensive molecular imaging portfolio at the 2006 Society of Nuclear Medicine Annual Meeting (SNM), held June 4-7 in San Diego. Recognizing the call for advanced technologies in several clinical areas, Siemens is developing solutions that expand the fields of oncology, cardiology and neurology.

Siemens sees the evolving field of molecular medicine as a means to move healthcare from treating illness to promoting health through efficient prevention, accurate diagnosis, personalized therapy, and high quality care, explains Michael Reitermann, president, Molecular Imaging Division, Siemens Medical Solutions. Molecular medicine is expected to help physicians detect diseases earlier, and more specifically, to forecast the effectiveness of drugs for a patient and determine the best therapy on a personalized basis.

Molecular imaging is a key transforming technology in this evolution, and Siemens has made tremendous strides in this arena since its acquisition and successful integration of CTI Molecular Imaging in May 2005. True integration of innovative hardware and advanced software applications has enabled workflow-oriented solutions that create reproducible results while facilitating quicker and more precise diagnoses.


"The past year has shown the tremendous promise of the Siemens Molecular Imaging organization and we're proud to have demonstrated our commitment to the future of personalized medicine," said Reitermann. "It's obvious that a passion for innovation is indeed in Siemens' genes as we actively look to leverage innovations in areas that include oncology, neurology and cardiology."

Molecular imaging's ability to provide anatomical and functional detail at the cellular level can greatly impact these areas because treatment and survival are dependent upon early, accurate diagnosis and monitoring. Siemens' molecular imaging technologies, including clinical and preclinical imagers, advanced applications and biomarkers, are enabling clinicians and researchers around the world to effectively treat within and further explore these areas.

"Siemens' solutions are driving research from the bench to the bedside, where it is most needed to increase the quality of healthcare delivery, while reducing costs," said Reitermann.

Siemens highlighted molecular imaging solutions suited for a variety of environments at this year's SNM, including:

More Industry Headlines